Bombay Hospital Journal ContentsHomeArchivesSearchBooksFeedback


Home > Table of Contents > Original / Research Articles
 
Diagnostic Importance of Antibodies TBIgG and IgA and AdenosineDeaminase in Tuberculous Pleural Effusion in Indian Population
JG Saluja*, MS Ajinkya**, S Khanna***
 

Tuberculosis is still common in India and Tuberculosis pleural effusion is one of the most common forms of tuberculosis pleural effusion can be established.

Directly : By demonstrating tubercle bacilli in pleural effusion fluid, or pleural biopsy, or Antigen or Antibody detection in either sputum, pleural fluid by polymerase chain reaction (PCR) of Mycobacterium tuberculosis.

Indirectly : Evidence with granuloma in pleural or increased level of pleural fluid Adenosine deaminase.

The study of comparative diagnostic value of serum and pleural effusion fluid. Antibody test (TBIgG, IgA) and adenosine deaminase (ADA) test was done in age group above 14 years because TBIgG titres in primary tuberculosis reported to be lower than in post primary tuberculosis. The results obtained were showing significant higher titres of Antibodies in pleural fluid than serum Antibodies levels. Similarly Adenosine deaminase values were found to have a sensitivity of 96% and specificity of 96% in pleural effusion than serum values. Therefore it is concluded that it is possible to avoid pleural biopsy and do pleural fluid ADA TBIgG, TBIgA to ascertain the diagnosis of tubercular pleuritis.

 
INTRODUCTION

Tuberculosis is a classic example of “host parasite” relationship. The host response in tuberculosis is the result of quantitative and qualitative interactions to various constituents of the wall of the bacillus which acting as foreign substance mobilize the immune response of the host. The net result is due to the interplay of cell-mediated immunity and delayed hypersensitivity.1

Tubercle bacilli, when they infect man are rapidly phagocytosed by Polymorph-neutrophils cells, in which they rapidly multiply and then kill them. Next, the battle is taken up by macrophages, which are derived from bone marrow and constitute the reticuloendothelial system. In lungs they are concentrated as alveolar macrophages, which play an important role in defense against tubercle bacilli. Macrophages are the body’s mechanism for expressing Tuberculo-Immunity. But how, it is a mystery. Later on it was established that lymphocytes from immune animals were the “Affecter Cells”. It is proved that immunity to tuberculosis was lymphokine mediated. Lymphokines are produced by lymphocytes. The lymphocytes modulate the functions of macrophages, T cells are the “Affecter Cells” of cell-mediated immunity.2 They regulate all types of response by either activity as helper or suppressor cells. Tuberculosis is still common in India and tuberculosis pleural effusion is one of the most common forms of extra pulmonary tuberculosis. The diagnoses of tuberculosis pleural effusion can be established directly by Demonstrating tubercle bacilli in pleural effusion, fluid or pleural biopsy specimen or Antibody or antigen detection in either sputum or pleural fluid, pleural fluid polymerase chain reaction (PCR) for mycobacterium tuberculosis

Indirect evidence with granuloma in pleura or increased level of pleural fluid adenosine deaminase. A couple of antigens secreted by M tuberculosis have been purified, which are present both in inactive and active tuberculosis e.g. 17 Kda to 80 Kda were recognized by the IgG antibodies present in the plasma of active and inactive TB patients. These antigens3,4 are responsible for increasing humoralresponse (IgM, IgG, IgA) which usually peaks after the Tcell medicated immune response has declined. This antibody response shows promising results for the diagnoses of pulmonary and extra pulmonary tuberculosis. However, recent reports have revealed a discrepancy in different study populations.

The aim of this study is to confirm the comparative diagnostic value of serum and pleural fluid effusion, antibody test (IgG, IgA) and ADA test in patients presenting with pleural effusion.

 
Methodology

Fifty patients who underwent diagnostic evaluation for pleural effusion between March 1999 and March 2002 at Mumbadevi Homoeopathic Hospital Pathology Laboratory along with 50 non-Tuberculous Pleural effusion (Lymphocytic) patients who were enrolled in this study. The patients were aged 13 years or more and were diagnosed as having pleural effusion by clinical symptoms, physical examination and radiographic evidence. Patients with clinical suspicion of human deficiency virus co-infection were tested after counselling.

Pleural tap was performed under local anaesthesia and aseptic precaution.

About 50 ml of fluid was collected

5 ml for cell count and differential count

The diagnostic criteria were MT +ve, Pleural fluid TB IgG, IgA +ve or -ve.

25 ml for protein and sugar and adenine deaminase

5 ml for antibody estimation TB IgG, IgA, by ELISA technique.

Simultaneously serum sample were also collected for ADA and TB IgG, TB IgA were estimated by ELISA (enzyme linked immuno-sorbant Assay). Using Andaelisa mycobacterium karactac kit Deaminase by deaminase kit by Giust’s method.

Pleural fluid sugar, proteins by GODPOD and Biurete from Ranbaxy Ltd. and Biolab Ltd. Mantoux test (intradermal test) by using PPD from Span Diagnostic 10 Tu.

Lymphocyte count increased in pleural fluid, Protein increased; sugar decreased in pleural fluid and haemorrhage in pleural fluids were determined. Any one or two positive parameters were considered for diagnosis.

TB IgG values
Positive more than 225 units
Negative less than 125 units
Equivocal between 125-225 units
TB IgA values
Greater 1.2 units Positive
Less than 0.8 units Negative
Between 0.8-1.2 units Equivocal
Adenosine deaminase value above 70 units were considered Positive MT Criteria Area induration and Erythema
No Induration
5.0 - 10.0 mm
10.0 - 15.0 mm
15.0 - 25.0 mm
-ve
+ve
++ve
+++ve to ++++ve
Mantoux Test
- Anergic (A)
- Reactive
- Intermediate Reactive (IR)
- Intermediate Anergic (IA)
10 Tu
8%
58%
28%
6%
TB IgG 99% +ve in Pleural Fluid
70% +ve in Serum
01% -ve in Pleural Fluid
30% -ve in Serum
TB IgA 78% +ve in Pleural fluid
74% +ve in Serum
22% -ve Pleural Fluid
23% -ve in Serum
02% Borderline /Equivocal (in Serum)
ADA 96% +ve in Pleural Fluid
52% +ve in Serum
04% -ve in Pleural Fluid
48% -ve in Serum
M IgG +ve IgA - ve
M IgG +ve IgA +ve
M (A) IgG +ve IgA -ve
M (IR) IgG +ve IgA -ve
M (A) IgG +ve IgA +ve
6%
28%
2%
8%
0%
 
Humoral antibody response in 3 HIV +ve cases was good
10 patients were showing AFB +ve of those
TBIgG values in pleural fluid were ranging 1000-2000
TBIgA values were +ve in 8 cases 6 in serum, 2 in pleural fluid and Equivocal in 2 cases.
TBIgG value in serum were ranging 200-400
 
Results
 
Control study of 50 Non-tuberculous pleural effusion (Lymphocytic) shows following results
X-ray Old fibrotic lesion 1 patient
  Old fibrotic scar upper/ middle zone 8 patients
  Thickening of pleura 2 patients
  Infiltration lesion healed 1 patient
Serum IgG
Upper limit of normal 9 patients
  Borderline 3 patients
  Equivocal 1 patient
Serum IgA Equivocal 6 patients
  Borderline 3 patients
Pleural ADA
Positive 2 patients
    (Between 80-90)
From the above study the results were represented in graphical form.
 
Statistical Significance
The significance of the above test was studied i.e Pleural ADA Test with respect to specificity and sensitivity. Where in we took
-Positive Tubercular sample Pleural Effusion
sample as
Truely Positive of ADA = 48
False Positive ADA Test = 02
-Negative Tubercular Sample of Pleural effusion of Lymphocytic Effusion (Non-Tuberculous pts) was studied and following values were observed.
- Truly Negative = 48
False Negative = 02
On this basis Sensitivity/Specificity is calculated
Sensitivity = 96%
Specificity = 96%
Positive predictive value of test = 96%
Negative predictive value = 96%
Positive diagnostic ratios (DLR) = 24
Negative (DLR) = 0.04
Fig 1


Fig 2


Fig 3
 
Discussion

Tuberculosis is entirely regulated by cell mediated immune response (CMI) of the host. When bacillary antigens are present at low levels the CMI response causes macrophages to accumulate, get activated and then destroy the bacilli. When the bacillary antigen are present at high levels the CMI response causes necrosis of tissue.5-6

Immune response against myc. Tuberculosis involves both macrophages and lymphocytes, dead organism, are broken down relatively within the granuloma, releasing large quantities of glyco-lipid and polysaccharides, antigen into the draining lymphnodes leads to predominately humoral immune response.

But viable mycobacterium release small quantities of glycoproteins, antigen which induces a delayed hyper sensitivity and cell mediated immune response.

When more and more tubercle bacilli are killed by the immune host, good amount of glycolipid and polysaccharide antigens are released from the cell wall of Mycobacterium Tuberculosis. These antigens are responsible for increasing humoral response (IgM IgA) which peak after the T cell mediated immune response has declined.7,8

TBIgA has a potent inflammatory potential. Immune complexes with IgA activate complement and can trigger inflammation in different organs. During an infection (Asymptomatic or overt), the production of IgA antibodies occur usually after the initial surge of IgM antibodies. The presence of IgA antibodies occur usually after the initial surge of IgM antibodies. The presence of IgA antibodies in the serum, sputum other biological fluids of tuberculosis patients indicates that the immunological response of these patients has been partially or totally misdirected, on rare occasions, it is the only specific antibody that can be detected. Its search is thus warranted when an immune anergy has depressed the synthesis of IgM and IgG antibodies.9-12

In tuberculosis patients suffering from extrapulmonary infections. The presence of IgA antibodies detected in body fluids at a 1:20 dilution (pleural fluid, pericardial etc.) is a sure sign of a mycobacterial infection and its detection in these fluids is, in difficult cases a precious diagnostic clue that complements the seric detection of TBIgM antibodies.13,14

TBIgG antibodies appear when an infection becomes established. This indicates a good immunological response of the patients to the infection.

TBIgM plus TBIgG measurements are analyzed together to detect reactivation cases in chronic infection.

TBIgM plus TBIgG measurements are analyzed together to detect reactivation cases in chronic infection.

TBIgG antibodies are routinely analysed in chronic infection and during therapy. They give an evaluation of the activity of the disease. A successful therapy, is often accompanied by an increase in IgG titres, followed of course by a decrease at the end of the therapy.15-16 Persistence of low levels of antibodies after therapy is supposed to indicate the presence of non-evacuated antigenic pouches. TBIgA antibodies are applied in difficult cases presenting an anergy i.e. lack of tuberculin reactivity and no synthesis of IgG antibodies TBIgA antibodies strengthen the diagnosis in cases of suspected meningitis, pleuritis and pericarditis renal tuberculosis and AIDS syndrome.16

In the present study pleural fluid TBIgG and TBIgA antibodies and ADA values were significantly higher than in serum.

Higher Titres of TBIgG were supposed to be due to active disease which can be clearly distinguish from control. TBIgG (Anti 60 to IgG) were supposed to be more specific than total IgG levels. Many workers have reported lower IgG titres in primary tuberculosis than in past primary tuberculosis. This might be the reason of low positivity in 0-14 yrs of age group patients as chances of primary TB aremore in younger patient11-12 Patel et al have been also reported low of sero positivity in childhood tuberculosis.5-8

ADA levels in non-tubercular lymph pleural effusion seldom exceeds the diagnostic cut off for TB effusion.17-19 ADA levels cannot be predicted from total or differentiated Leucocyte count. ADA is stable in effusion fluid and it is measurement in reproducible in pleural fluid ADA were significantly higher in TB as compared with control group. Pleural fluid ADA were higher than serum ADA in TB as compared with control group.20-23

Pleural fluid ADA was found to have a sensitivity of 96% and specificity of 96%. The mean values of pleural fluid ADA in tuberculosis group were higher positive, which was significantly higher than control group. Because of low sensitivity of microscopic examination of pleural fluid for tubercular bacilli. Pleural fluid ADA may be investigation of choice in diagnosis of tuberculous pleuritis and pleural biopsy in selected cases.24-26

From the study it is concluded that it is possible to avoid pleural biopsy and do pleural fluid ADA, TBIgA TBIgG to ascertain the diagnosis of Tubercular Pleuritis.

 
Acknowledgement
We are grateful to the Dean Dr. SK Goel for giving permission to publish the data. We also express the deep gratitude to Mr. Leroy Rebello (Student of III year medicine). Dr. Prachi Bedekar Junior Lecturer of Pathology and Mrs. Uma A Clerk (Pathology staff) from RRI for helping us in preparing the manuscript and reference work.
 
References
1. Butreau JW. Nosocomial urinary tract infection. Progress on urologic 1997; 7 (4) : 674-82.
2. Carlo G Cocito. Properties of mycobacterial antigen complex A60 and its application to diagnosis and prognosis of tuberculosis. Chest 1991; 100 : 1687
3. Grange JM. The humoral immune response in tuberculosis: its nature biological role and diagnostic usefulness adv. Tuberculosis Res 1984; 21 : 1.
4. Kramabovitis E. Serodiagnosis of tuberculosis in perspective. Serodiagnostic Immuno Ther 1987; 1 : 7.
5. Jacketi PS, Bothamley GH, Batra HV, et al. Specificities of antibodies to immunodominant mycobacterial antigens in pulmonary tuberculosis. J Clinical Microbiology 1998; 26 : 2323.
6. Patel AB, Rawat MS, et al. ELISA for diagnosis of tuberculosis. Indian Pediatr 1990; 27 (6) : 585 M27 : 164.
7. Singh MM, et al. ELISA in the diagnosis of pulmonary tuberculosis. Indian J Chest Disease All Sci 1985; m27 : 164.
8. Nagesh S Babu, Sehgal Shobha, et al. Evaluation of polymerase Chain Reaction for detection of Mycobacterium tuberculosis in pleural fluid. Chest 2001; 119 : 1737.
9. Brennan PJ. Structure of mycobacteria recent development in defining cell wall carbohydrates and proteins. Rev Infect Dis 1989; 11 (Suppl 12) : v5420
10. Charpin D, Charpin J, et al. Value of Elisa using A 60 Antigen in the diagnosis of Active Pulmonary Tuberculosis. American Review of Respiratory Disease 1990; 142 : 380-84.
11. Bogers W, Stad RK. Complement inflamm 1991; 8 : 347-58.
12. Ferreira P, Soares R, et al. Internet Immune 1991; 3 : 445-52.
13. Wayne L, et al. Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn’s disease patients and their relatives. Clinical Microbial 1992; 30 : 2013-18.
14. Zou YL, Zhang JD, et al. Serological analysis of pulmonary and extra pulmonary tuberculosis with enzyme-linked immunosorbent assays for Anti - 60 Immunoglobulins. Clinical Infection Disease 1994; 19 : 1084-91.
15. Kaustova J. Serological IgG, IgM and IgA. Diagnosis and Prognosis of Mycobacterial Disease in Routine Practice. Euro J Med Disease 1995; 961 : 393-403.
16. Maes HH, Maes RF, et al. Mycobacterial infections are the observed enigmas and paradoxes explained by immuno suppression and immunodeficiency? Medical hypothesis 1996; 46 : 163-71.
17. Gupta S, Kumar S, et al. Diagnostic utility of the estimation of Mycobacterial Antigen 60 Specific Immunoglobulins IgM, IgA and IgG in the sera of cases of adult human tuberculosis. Tubercle and Lung Disease 1995; 76 : 418-24.
18. Lee YC, Rogers JT, Miller KD, et al. Adenosine deaminase levels in non-tuberculosis lymphocyte pleural effusion. Chest 2001; 120 (2) : 334-6.
19. Fijalkowsk, Graczyk M. Tuberculous pleurisy-still difficult diagnostic problem. Pol Mer Kuriusz Lek 2001; 11 (63) : 389-93.
20. Chierakul N, Damrongchokpioat R, et al. Antibody detection for diagnosis of tuberculosis pleuritis. Int J Tuberc Lung Dis 2001; 5 (10) : 968-72.
21. Gronge JM. The humoral immune response in tuberculosis its nature, biological role and diagnostic usefulness. Adv Tuberc Res 1984; 163 : 10224.
22. Reechaipichit kul w Kawamatawong, et al. Diagnostic role of pleural fluid adenosine deaminase in tuberculous pleural effusion. Southeast Asian J Trop Med Public Health 2001; 32 (2) : 383-9.
23. Luzze H, Elliot AM, Joloba ML, et al. Evaluation of suspected tuberculosis pleurisy: Clinical and diagnostic findings in HIV 1 positive and HIV negative adults in Uganda. Int J Tuber Lung Disease 2001; 5 (8) : 746-53.
24. Lawn SD, Pisell TL, et al. Anatomically compartmentalized human immunodeficiency virus replication in HLA DR +cells and CD 14 + macrophages at the site of pleural tuberculosis coinfection. J Infect Dis 2001; 1 : 184 (9) : 1127-33.
25. Sharma SK, Suresh V, Mohan A, et al. A perspective study of sensitivity and specificity in the diagnosis of tuberculosis pleural effusion. Indian J Chest Dis Allied Sci 2001; 43 (3) : 149-55.
26. Carrion - Valero F, Perpina-Tordera N. Screening of tuberculous pleural effusion by discriminant analysis. Int J Tuberc Lung Dis 2001; 5 (7) : 673-9.
27. Hubbard RD, Flory CM, et al. Immunization of mice with mycobacterial culture filtrate proteins. Clin Exp Immunol 1991; 187 : 94.
28. Rapid Diagnostic Tests : Accurate Diagnostic Tests. http://www.Rapid diagnostic.org/accuracy.htm.

 

Hospitals in India woo foreign patients

The British woman is among a growing number of foreigners turning to private tertiary care hospitals in India for medical treatment, which is leading to health tourism. Large hospitals in Mumbai, Chennai and New Delhi have long been receiving patients from neighbouring South Asian and Gulf countries. Now they are trying to attract patients from Africa, Europe, and North America, marketing themselves as centres capable of delivering world class medical services at low cost.

The Indian government has also signalled its intention to promote medical tourism, but this has evoked criticism from health sector analysts. “Where is the logic of the government spending energy and effort to attract foreign patients for the private sector when an over-whelming majority of patients in India have inadequate access to health care.”

Whether it is for cataract or cardiac surgery, dental treatment, or hip replacement operations, treatment cost in India is a fraction of what an identical procedure would cost in Europe or North America.

The Escorts Heart Institute is among the hospitals approved by the UK medical insurance company BUPA.

BMJ, 2004; 328 : 1338.